Press Release

Eckert & Ziegler to Acquire f-con Europe GmbH

(Ad hoc press release)

Berlin, 30.06.2005. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in radioactive components for medical and industrial use will acquire 51% of the shares of f-con Europe GmbH, as of July 1, 2005. In order to differentiate from the Austrian f-con Groupe the company's name will be changed to Eckert & Ziegler f-con Europe GmbH. The Hesse based company distributes radioactive glucose (PET tracer) through its subsidiaries in Germany and Italy. The radioactive glucose is used to diagnose cancer with the so called Positron Emission Tomography (PET). In 2004 the company achieved sales of approximately 3 Mio EUR. The general manager of Eckert & Ziegler f-con Europe GmbH will be Axel Schmidt, a radio chemist with long standing expert knowledge, who brings an experienced team into the group.

The Board of Directors